Atlas Trials

Comparative Study of the Quality of Life of Patients Suffering From OTOTOXICITY Due to Chemotherapy Based on Platinum Salts Fitted With a Hearing Aid Compared to Those Not Fitted.

Clinical trial NCT05936034 · RECRUITING

Trial details

NCT number
NCT05936034
Sponsor
Institut de Cancérologie de Lorraine
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
CancerOtotoxicity, Drug-InducedQuality of LifeHearing Disorders
Start date
2024-01-04
Primary completion
2027-09-04
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.